Back
Apellis Pharmaceuticals Vs. Regencell Bioscience Holdings Industry Stock Comparison
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$19.09
Seasonality Move:
-8.3%
Sell
29
RGC
Regencell Bioscience Holdings
Last Price:
$14.05
Seasonality Move:
23.7%
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.59. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Regencell Bioscience Holdings (RGC)
is a Sell
Is Regencell Bioscience Holdings a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings [RGC] share price is $15.05. The Score for RGC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
RGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.59The current trend is moderately bullish and APLS is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings's stock price today?
-
The Regencell Bioscience Holdings share price today is $15.05The current trend is moderately bullish and RGC is experiencing slight buying pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 54.73 | Buy |
| Chaikin Money Flow: | -1363320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.86 - 19.76) | Buy |
| Bollinger Bands (100): | (17.19 - 22.45) | Sell |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.52 | Buy |
| Relative Strength Index (14 RSI): | 46.48 | Sell |
| Chaikin Money Flow: | 57890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.36 - 22.96) | Sell |
| Bollinger Bands (100): | (-2.44 - 23.42) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.75 | Sell |
| 20-day SMA: | 18.97 | Buy |
| 50-day SMA: | 18.45 | Buy |
| 200-day SMA: | 24.83 | Sell |
| 8-day EMA: | 19.67 | Sell |
| 20-day EMA: | 19.24 | Buy |
| 50-day EMA: | 19.13 | Buy |
| 200-day EMA: | 25.25 | Sell |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.72 | Buy |
| 20-day SMA: | 15.75 | Sell |
| 50-day SMA: | 19.37 | Sell |
| 200-day SMA: | 5.31 | Buy |
| 8-day EMA: | 14.39 | Buy |
| 20-day EMA: | 11.31 | Buy |
| 50-day EMA: | 6.5 | Buy |
| 200-day EMA: | 1.99 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.39 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Regencell Bioscience Holdings Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Technical Analysis
| Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Technical Analysis
| Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 14 | 15 | 16 | 17 | 18 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||